Table 1.

Pharmacokinetics parameters after oral administration of BBH nanoemulsion and BBH suspension to rats (n = 6).

Parameters	BBH suspension	BBH nanoemulsion
AUC(0–24) (mg/L h)	1.681 ± 0.558	4.963 ± 2.952
AUC(0–∞) (mg/L h)	2.223 ± 0.810	9.790 ± 8.410
MRT(0–24) (h)	10.009 ± 1.239	10.188 ± 2.391
MRT(0–∞) (h)	17.944 ± 6.357	21.020 ± 10.950
t1/2z (h)	9.761 ± 6.611	10.737 ± 7.027
Tmax (h)	1. 141 ± 1.469	4.778 ± 5.645
Cmax (mg L−1)	0.259 ± 0.179	0.404 ± 0.13
Relative bioavailability		440.40%